Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Financing Activities (2016 - 2025)

Medicure has reported Cash from Financing Activities over the past 13 years, most recently at -$79596.6 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 7.34% year-over-year to -$79596.6; the TTM value through Dec 2025 reached -$297292.4, down 10.24%, while the annual FY2025 figure was -$297590.8, 12.36% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$79596.6 at Medicure, down from -$74116.8 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $511708.6 in Q2 2021 and troughed at -$916748.3 in Q3 2021.
  • A 5-year average of -$64863.9 and a median of -$61801.0 in 2024 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 149.52% in 2021 and later tumbled 143.1% in 2022.
  • Year by year, Cash from Financing Activities stood at $232447.5 in 2021, then tumbled by 143.1% to -$100191.6 in 2022, then skyrocketed by 47.21% to -$52886.6 in 2023, then tumbled by 62.43% to -$85901.9 in 2024, then increased by 7.34% to -$79596.6 in 2025.
  • Business Quant data shows Cash from Financing Activities for MCUJF at -$79596.6 in Q4 2025, -$74116.8 in Q3 2025, and -$81553.5 in Q2 2025.